GLP-3 – 60mg is a synthetic dual GLP-1 and GIP receptor agonist peptide explored for its effects on metabolic balance, glucose regulation, and weight management. Extensively studied for obesity and type 2 diabetes research, GLP-3 enhances insulin sensitivity, supports fat metabolism, and may aid in appetite control.
Potential Research Applications
GLP-3 is currently being explored in research settings for its role in:
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
$900.00
GLP-3 is a research-grade peptide designed to target both GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors simultaneously. This dual receptor activity makes it an innovative compound for studies on metabolism, glucose control, and energy homeostasis.
By influencing these two critical pathways, GLP-3 may provide a balanced approach to metabolic regulation, supporting ongoing research into obesity, insulin resistance, and type 2 diabetes.
The synergy of these two actions makes GLP-3 a valuable tool in metabolic peptide research.
Through its dual receptor agonism, GLP-3 helps researchers understand complex metabolic interactions that influence energy regulation and body composition.
GLP-3 – 60mg is primarily used in:
Preclinical findings indicate that GLP-3 may enhance insulin secretion, improve glucose tolerance, and reduce food intake. By influencing both GLP-1 and GIP pathways, GLP-3 offers comprehensive metabolic regulation potential, making it an essential peptide for advanced metabolic health research.
For Research Use Only
Not intended for human consumption. GLP-3 – 60mg is exclusively for scientific and laboratory research purposes.
copyright content
Reviews
There are no reviews yet.